When people think about bringing a medical product to market, they often focus on the regulatory submission. Whether it's a 510(k), De Novo, PMA, CE Mark, or another market authorization, the submission is typically seen as the finish line.
In reality, it's only one milestone in a much larger commercialization journey.
Many of the delays that impact timelines, budgets, and market entry don't occur during the review process—they originate months earlier.
Many of the delays that impact timelines, budgets, and market entry don't occur during the review process—they originate months earlier. Decisions made during product development around regulatory strategy, quality systems, clinical evidence, software, cybersecurity, reimbursement, and market access can significantly influence the speed and success of commercialization.
A well-defined commercialization roadmap helps organizations answer critical questions early:
- What is the most appropriate regulatory pathway?
- Does the Quality Management System support current and future submissions?
- Is the clinical evidence strategy aligned with regulatory expectations?
- Have software and cybersecurity requirements been addressed?
- What reimbursement and market access considerations should be incorporated now rather than later?
- How can global market requirements be integrated into a single development strategy?
Addressing these questions early reduces unnecessary rework, minimizes regulatory risk, and helps development teams make informed decisions throughout the product lifecycle.
At RQMIS, we partner with medical product companies from concept through commercialization, providing integrated support across regulatory affairs, quality systems, clinical research, cybersecurity, reimbursement, and global market access. Our team includes former FDA reviewers and experienced industry specialists who help organizations develop practical, efficient strategies that keep programs moving forward.
Successful commercialization isn't defined by a single submission—it's built on the strategic decisions made long before that submission reaches a regulatory agency.
The best time to plan for market success is at the beginning of the journey.